Clinical Trial Update: Study to Assess Efficacy and Safety of Bulevirtide in Participants With Chronic Hepatitis Delta (CHD) [Phase 3]

View source ↗

Summary

This update reports the results of a Phase 3 study evaluating the efficacy and safety of bulevirtide in participants with chronic Hepatitis Delta; results were …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Hepatitis Delta

Drugs mentioned

• Hepcludex (bulevirtide)

Snippet

Sponsor: Gilead Sciences | Conditions: Chronic Hepatitis Delta | Phase 3 | Status: COMPLETED | Results posted: 2022-10-28